Clinical characteristics of patients (probands and their relatives) with either MODY, FDA or T2DM.

Continuous variables were reported as mean + SD, whereas categorical variables are reported as percentages. FDA: Familial Diabetes of the Adulthood; MODY: Maturity Onset Diabetes of the Young; T2DM: Type 2 Diabetes Mellitus; HbA1c: Glycated hemoglobin; OADs: Oral Antidiabetes Drugs *: p<0.001 vs. T2DM patients †: p≤0.01 vs. MODY patients **: p<0.05 vs. T2DM patients ††: p≤0.05 vs. MODY patients. Because of the well-known differences across the two clinical entities, no comparisons were carried out between MODY and T2DM. Clinical characteristics of patients (probands and their relatives) with either MODY, FDA or T2DM.